product Image
[DR] DiaStar™ RT Series (cDNA Synthesis)
Model Name
-
Series
Research Reagents (PCR)
Data
메뉴얼-솔젠트-DR22-R10k_DiaStar™_RT_Kit_with_RNase_Inhibitor
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125182
Product Name
[DR] DiaStar™ RT Series (cDNA Synthesis)
Model Name
-
Size
-
Weight
-
Product Details

[DR] DiaStar™ RT Series

For cDNA synthesis with high sensitivity & high efficiency from Template RNA


Diastar™ RT Kit is a thermostable mutant of M-MLV Reverse Transcriptase (Rnase H-) which is recombinant type. This mutant type of Rnase H- enables more efficient cDNA synthesis due to more thermostable characteristic (optimal activity at 50 ℃).



Specification

SourceM-MLV (Recombinant)H Gene-specific primer -~ 14 kb
Reaction temperature42 – 55 ℃Applicable PrimersRandom primer, Oligo d(T) primer, Gene-specific primer



Application

- First-strand cDNA synthesis, Two-Step RT-PCR (conventional and real-time PCR), cDNA library construction, Primer extension analysis




Citation&Papers

Ramasamy H,

Kim MC, et al., Immune response and expression analysis of cathepsin K in goldfish during Aeromonas hydrophila infection, Fish & Shellfish Immunology, 28 : 511-516, 2010

Chen XY, Lin Liu,

et al., The Arabidopsis Callose Synthase Gene GSL8 Is Required for Cytokinesis and Cell Patterning, Plant Physiology, 150 :105-113, 2009





Format

FormatProduct ImageContentsStorage & Expiry Date
Standard

DiaStar™ RTase (200 U/㎕)
5X RT Reaction Buffer (Included 10 mM dNTP mix)
8 mM DTT
(Option) RNase Inhibitor
DiaStar™ RT Kit
: 2 years 3 months (In case of Store at -20 ℃ ± 5 ℃)
RNase Inhibitor
: 1 year 6 months (In case of Store at -20 ℃ ± 5 ℃)
Pre-Mix

2X RT Pre-Mix1 year 6 months (In case of Store at -20 ℃ ± 5 ℃)





Ordering information

FormatCat. No.ProductSizePrice (won)
StandardDR22-R10kDiaStar™ RT Kit, with RNase Inhibitor
(RTase (M-MLV, RNase H-), Reaction Buffer (Included 10 mM dNTP), 8 mM DTT, RNase Inhibitor)
10,000 U
(200 U/㎕)
(50 reaction)
-
DR23-R10kDiaStar™ RT Kit
(RTase (M-MLV, RNase H-), Reaction Buffer (Included 10 mM dNTP), 8 mM DTT)
10,000 U
(200 U/㎕)
-
Pre-MixDR41-P096DiaStar™ 2X RT Pre-Mix, w/o dye, total volume 20 ㎕ reaction96 tube
(8 strip x 12 ea)
-
Single itemDR28-B50hDiaStar™ 5X RT Reaction Buffer (Included 10 mM dNTP)1 ㎖ x 5 ea
(1,250 reaction)
-
SOR51-E20hSolg™ RNase Inhibitor2,000 U
(40 U/㎕)
-
SOR51-E10kSolg™ RNase Inhibitor10,000 U
(40 U/㎕)
-




More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry